Clinical Trial: Evaluation of the Safety and Performance of the AWAKE Device in Patients With Hemiplegia or Hemiparesis Secondary to Stroke (ACV).

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867847) titled 'Evaluation of the Safety and Performance of the AWAKE Device in Patients With Hemiplegia or Hemiparesis Secondary to Stroke (ACV).' on Sept. 22.

Brief Summary: Stroke is a leading cause of disability in adults, with gait impairment being a key functional limitation. Although lower limb exoskeletons are used in rehabilitation, the available evidence focuses on bilateral devices used in clinical settings with continuous supervision by healthcare professionals, and is limited for solutions with alternative configurations and usage conditions.

The AWAKE device is designed as a compensatory solution for gait impairment following stroke....